Frequency of elevations in markers of cardiomyocyte damage in otherwise healthy newborns.
Myocardial damage in infancy is a risk factor for eventual cardiac disease. Given that myocardial stress is greatest during the perinatal period and that the neonatal period is when most pediatric heart failure occurs, the aim of this study was to determine whether even otherwise healthy neonates might have subclinical myocardial damage and, if so, what characteristics might identify them. Umbilical cord and neonatal serum samples from 32 normal neonates were assayed for biomarkers of myocardial injury. No neonate had clinical evidence of cardiac or other abnormalities. Serum cardiac troponin T was elevated in 19 of 25 cords (76%) and in 16 of 17 neonates (94%); levels indicating myocardial infarction (> or =0.2 ng/ml) were found in 2 patients (1 umbilical cord and 1 neonatal sample). Creatine kinase-MB was elevated in 6 of 16 cords (38%) and in 8 of 15 neonates (53%). Cardiac troponin I was elevated in 11% and 17% of samples, myoglobin in 4% and 17%, and high-sensitivity C-reactive protein in 9% and 40%. Measures of myocardial injury were associated with longer hospitalization (r = 0.50, p = 0.04), non-Caucasian race (p = 0.012), lower birth weights (p = 0.014), positive maternal cervical cultures (r = 0.41, p = 0.046), and elevated high-sensitivity C-reactive protein (r = 0.66, p = 0.005). In conclusion, clinically occult myocardial injury appears to occur in some healthy newborns, although whether it is pathologic or not remains to be determined.
Lipshultz
Steven E
SE
Department of Pediatrics, University of Miami Leonard M. Miller School of Medicine, Miami, Florida, USA. slipshultz@med.miami.edu
Simbre
Valeriano C
VC
Hart
Sema
S
Rifai
Nader
N
Lipsitz
Stuart R
SR
Reubens
Linda
L
Sinkin
Robert A
RA
D015415:Biomarkers / Q000097:blood; D001724:Birth Weight; D002097:C-Reactive Protein / Q000032:analysis; D002584:Cervix Uteri / Q000382:microbiology; D002585:Cesarean Section; D052279:Creatine Kinase, MB Form / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000166:cytology; D006801:Humans; D007231:Infant, Newborn; D007902:Length of Stay / Q000706:statistics & numerical data; D008297:Male; D009203:Myocardial Infarction / Q000097:blood*; D032383:Myocytes, Cardiac / Q000473:pathology*; D009211:Myoglobin / Q000097:blood; D011247:Pregnancy; D044469:Racial Groups; D012494:Sampling Studies; D012737:Sex Factors; D019210:Troponin I / Q000097:blood; D020107:Troponin T / Q000097:blood
D015415:Biomarkers; D009211:Myoglobin; D019210:Troponin I; D020107:Troponin T; D002097:C-Reactive Protein; D052279:Creatine Kinase, MB Form
J Pediatr. 1991 Sep;119(3):417-23
1880657
Clin Chem. 2004 Sep;50(9):1717-8
15331524
Croat Med J. 2005 Oct;46(5):801-7
16158475
J Matern Fetal Neonatal Med. 2002 Jun;11(6):385-90
12389653
Res Vet Sci. 1995 May;58(3):244-7
7659849
Clin Obstet Gynecol. 2007 Sep;50(3):652-83
17762416
Eur J Pediatr. 2006 Feb;165(2):87-93
16228245
Biometrics. 1996 Jun;52(2):751-62
8672711
Am J Cardiol. 2002 May 1;89(9):1035-41
11988191
Arch Dis Child Fetal Neonatal Ed. 2004 Jul;89(4):F348-52
15210673
Int J Cardiol. 2007 Apr 25;117(2):198-203
16887211
N Engl J Med. 2003 Apr 24;348(17):1647-55
12711739
J Perinat Med. 2005;33(1):54-9
15841615
Pediatr Cardiol. 2002 Sep-Oct;23(5):531-5
12211203
Am Heart J. 2008 Mar;155(3):527-33
18294492
Am J Epidemiol. 2005 Dec 1;162(11):1108-13
16236995
Pediatr Cardiol. 2005 Jan-Feb;26(1):45-9
15793653
Lancet. 2002 Aug 3;360(9330):368-73
12241776
Am Heart J. 2006 Apr;151(4):916-22
16569563
Am J Perinatol. 2004 Apr;21(3):147-52
15085497
Arch Dis Child Fetal Neonatal Ed. 2001 Jan;84(1):F34-7
11124921
Pediatr Cardiol. 2001 Sep-Oct;22(5):393-6
11526413
Clin Biochem. 1999 Aug;32(6):419-21
10667476
J Matern Fetal Neonatal Med. 2004 Nov;16(5):315-9
15621550
N Engl J Med. 2004 Jul 8;351(2):145-53
15247354
Neonatology. 2008;94(1):1-7
18097151
J Clin Oncol. 2005 Apr 20;23(12):2629-36
15837978
Acta Paediatr. 2003 Dec;92(12):1463-7
14971799
Circulation. 1997 Oct 21;96(8):2641-8
9355905